Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · Davis New York Venture

Davis Research Fund (DRFAX)

Ticker DRFAX · · Holdings as of Jul 31, 2026

Expense ratio
0.68%$68/yr per $10k
5-yr return
+9.9%annualized
1-yr return
+13.6%as of Dec 2024
Net assets
$88.5Mall share classes
Holdings
66

Bottom line

Is DRFAX a good fund? The bottom line

DRFAX is an actively managed large blend mutual fund from Davis New York Venture.

Annual fees run 0.68% — about $68 a year on every $10,000 invested, cheaper than 63% of large blend funds we track.

It returned +13.6% over one year, +9.9% a year over five years, +10.0% a year over ten (as of Dec 31, 2024, per its prospectus).

With $88.5 million in net assets and 66 holdings, its largest position is Amazon.com Inc (7.9%) and the top 10 make up 43.4% of the portfolio.

This share class carries a front-end sales charge of up to 4.75%; a no-load class or ETF alternative can avoid it.

What to watch

  • Front-end sales load up to 4.75%

Updated Nov 19, 2026

What DRFAX invests in

The Fund seeks long-term growth of capital.

Davis Selected Advisers, L.P. (Davis Advisors or the Adviser), the Funds investment adviser, uses the Davis Investment Discipline to invest the majority of the Funds assets in equity securities (typically common stocks, but may also include preferred stocks, Depositary Receipts (as defined below), convertible bonds, and other forms of equity securities) issued by medium- and large-capitalization companies. The Fund considers companies with market capitalizations between $3 billion and $10 billion to be medium-capitalization companies and companies with market capitalizations of at least $10 billion to be large-capitalization companies. The Fund has the flexibility to invest in foreign securities. Davis Investment Discipline. Davis Advisors manages equity funds using the Davis Investment Discipline. Davis Advisors conducts extensive research to try to identify businesses that possess…

From the fund's prospectus (filed Nov 26, 2025).

DRFAX performance

Fund calendar-year total returns, 2015–2024 2015: +0.1%; 2016: +8.8%; 2017: +27.3%; 2018: −11.2%; 2019: +31.9%; 2020: +21.0%; 2021: +11.8%; 2022: −19.1%; 2023: +28.7%; 2024: +19.3% +0% 2015 +9% 2016 +27% 2017 −11% 2018 +32% 2019 +21% 2020 +12% 2021 −19% 2022 +29% 2023 +19% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
DRFAX+13.6%+9.9%+10.0%
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2024

Full DRFAX performance history →

What DRFAX costs

On a $10,000 investment, DRFAX's 0.68% expense ratio costs about $68 a year. The prospectus estimates $1,281 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full DRFAX fee table →

DRFAX top 10 holdings

#Holding% of fund
1Amazon.com Inc AMZN7.87%
2Microsoft Corp MSFT5.98%
3Stonex Repo5.08%
4Sap Se SAP4.95%
5Berkshire Hathaway Inc Cl B BRK.B3.90%
6US Bancorp USB3.85%
7Markel Group Inc MKL3.51%
8Nomura Repo2.95%
9Capital One Financial Corp COF2.69%
10Fifth Third Bancorp FITB2.61%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 43.4% of the fund. See all top 25 holdings and asset mix →

Alternatives to DRFAX

More funds like DRFAX →

DRFAX FAQ

What is the expense ratio of DRFAX?
DRFAX's expense ratio is 0.68%, which works out to about $68 a year for every $10,000 invested. The prospectus estimates total costs of $1,281 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is DRFAX a good investment?
It depends on your goals, but the data points to: front-end sales load up to 4.75%. This is general information, not personalized advice.
What does DRFAX hold?
DRFAX's largest holdings are Amazon.com Inc (7.9%), Microsoft Corp (6.0%), Stonex Repo (5.1%), Sap Se (4.9%), Berkshire Hathaway Inc Cl B (3.9%). It holds 66 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is DRFAX's 5-year return?
DRFAX returned +9.9% a year over the five years ending Dec 31, 2024, and +10.0% a year over ten years. Past performance does not guarantee future results.
Does DRFAX have a sales load?
Yes. DRFAX has a maximum front-end sales charge of 4.75%.
Who manages DRFAX?
DRFAX is offered by Davis New York Venture through Davis New York Venture Fund Inc.